NNVC - NanoViricides, Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : NNVC - NanoViricides, Inc.

NNVC 1.850

-2.6%

Nov 7 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: donpat who wrote (2001)	9/6/2011 6:10:03 PM
From: donpat	Read Replies (1) of 12871

Common Cold Cure -Todd Rider Video interview Updated: Tuesday, 06 Sep 2011, 10:03 AM EDT Published : Tuesday, 06 Sep 2011, 10:03 AM EDT Kim Carrigan (FOX 25 / MyFoxBoston.com) - We all know it's just a matter of time until cold and flu season is upon us. Some researchers from the M.I.T. Lincoln Lab hope a new technology will soon do away with the sniffles and aches associated with a cold. Dr. Todd Rider, a senior staff scientist in Lincoln Laboratory's chemical, biological and nanoscale technologies group at M.I.T., sat down with Kim Carrigan to discuss this possible cure for the common cold. myfoxboston.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next